FDA Seeks Input on 510(k) eCopy Submission Requirements
Devicemakers can begin taking steps to comply with new electronic copy requirements for most types of FDA submissions, thanks to an FDA draft guidance.
The provision in this summer’s FDA Safety & Innovation Act doesn’t eliminate the need for a paper copy of submissions, but requires devicemakers to include an eCopy along with the paper version.
The draft, released Oct. 17, defines eCopies as exact electronic duplicates of paper submissions. The two may differ only where the electronic version includes content — such as extended raw data or videos — that is impractical, inappropriate or not feasible to submit on paper. “The critical attribute of an eCopy is that it must include in electronic form all data required for that submission type,” the draft states.
eCopies are required for 510(k)s, de novo applications, humanitarian device exemptions and traditional, modular and transitional PMAs.
Electronic submissions are about to go global, and the FDA is leading the way. If you understand the FDA’s requirements, you can satisfy any regulator worldwide.
If you don’t have your electronic submission process perfected, there’s no time to lose. Many drug, biologic and device companies can already measure the difference in dollars — through increased first-time acceptance rates, shorter FDA review times, and yes, speed to market. And with FDAnews’ Preparing for the New Electronic Submission Mandates, you can add your company’s name to the prepared list.
Come for this valuable opportunity to hear FDA officials discuss regulatory plans and objectives — and ask questions you need answered; learn from device industry experts, consultants and other experts with actionable tips and strategies you can take straight back to the office; and network with other professionals who understand your challenges; share war stories and insights over a drink. Register Today.Read More
The FDA's new enforcement plan makes one thing clear: Developing a successful CAPA program has never been more important. But creating an FDA-proof CAPA isn’t easy. If only you could pick the brain of someone who is coping successfully with CAPA — the best and the brightest, an industry leader who has devised programs, procedures and solutions that have put companies out in front with the FDA. Well, you can. Register today.Read More
The FDA’s cadre of freshly trained inspectors — many of whom come directly from industry — and increased focus on specialized inspections are making it harder than ever to predict the outcome of your next FDA inspection. Unless, of course, you have Surviving an FDA Inspection at your fingertips. If you could spend less than $400 to get your drug manufacturing facility fully prepared to face a tough inspection by the FDA, would you even hesitate? ... Of course not!